Biomimetic Virulomics for Capture and Identification of Cell-Type Specific Effector Proteins
- 20 September 2017
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 11 (12) , 11831-11838
Abstract
An unmet challenge in the study of disease is to accurately streamline the identification of important virulence factors. Traditional, genetically driven approaches miss biologically relevant markers due to discordance between the genome and proteome. Here, we developed a nanotechnology-enabled affinity enrichment strategy coupled with multiplexed quantitative proteomics, namely Biomimetic Virulomics, for successful identification of cell-type specific effector proteins of both prokaryotic and eukaryotic pathogens. We highlight the power of Biomimetic Virulomics by capturing known virulence factors in a high-throughput, cell-type guided fashion. Additionally, a comprehensive characterization of the membrane protein component of biomimetics utilized in this strategy is provided. Interfacing cell-derived nanomaterials with multiplexed quantitative proteomics allow for a specific targeting strategy of virulence factors that can be utilized for drug discovery against prominent human diseases.Keywords
Funding Information
- National Eye Institute (R01EY025947)
- Donald E. and Delia B. Baxter Foundation
- Ray Thomas Edwards Foundation
- Defense Threat Reduction Agency (HDTRA1-14-1-0064)
- Burroughs Wellcome Fund
- National Institute of General Medical Sciences (K12GM068524)
- Office of the President, University of California
This publication has 46 references indexed in Scilit:
- Cyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancerOncotarget, 2017
- Shotgun proteomics of bacterial pathogens: advances, challenges and clinical implicationsExpert Review of Proteomics, 2016
- Nanoparticle biointerfacing by platelet membrane cloakingNature, 2015
- Modulating Antibacterial Immunity via Bacterial Membrane-Coated NanoparticlesNano Letters, 2015
- Engineering red‐blood‐cell‐membrane–coated nanoparticles for broad biomedical applicationsAIChE Journal, 2015
- Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug DeliveryNano Letters, 2014
- Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticlesNanoscale, 2013
- A biomimetic nanosponge that absorbs pore-forming toxinsNature Nanotechnology, 2013
- Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functionsNature Nanotechnology, 2012
- Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platformProceedings of the National Academy of Sciences of the United States of America, 2011